Navigation Links
Aware, Inc. Reports First Quarter 2011 Financial Results
Date:4/26/2011

erty of their respective owners.AWARE, INC.CONSOLIDATED STATEMENTS OF OPERATIONS(In thousands, except per share data)(unaudited)Three Months Ended March 31, 20112010Revenue:Product sales

$5,078$4,651Services

829209Royalties

451756Total revenue

6,3585,616Costs and expenses:Cost of product sales (1)

1,2201,036Cost of services (1)

35772Research and development (1)

1,9612,035Selling and marketing (1)

1,0511,066General and administrative (1)

1,1971,402Total costs and expenses

5,7865,611Income from operations

5725Interest income

2018Income before provision for income taxes

59223Provision for income taxes

21Net income  

$590$22Net income – basic

$0.03$0.00Net income – diluted  

$0.03$0.00Weighted average shares – basic

20,21919,913Weighted average shares – diluted

20,82819,923(1) The amounts in the tables above include stock-based compensation as follows (in thousands):Three Months Ended March 31,20112010Cost of product sales

$2$2Cost of services

96Research and development

67114Sales and marketing

2238General and administrative

203185Total stock-based compensation costs

$303$345AWARE, INC.NON-GAAP FINANCIAL MEASURES AND RECONCILIATION(In thousands, except per share data)(unaudited)Three Months Ended March 31,20112010GAAP net income  

$590$22Stock-based compensation

303345Non-GAAP net income  

$893$367Three Months Ended March 31,20112010GAAP diluted net income per share

$0.03$0.00Stock-based compensation per share

0.010.02Non-GAAP diluted net income per share

$0.04$0.02AWARE, INC.CONDENSED CONSOLIDATED BALANCE SHEETS(In thousands)(unaudited)March 31, 2011December 31, 2010ASSETSCash and investments

$40,015$39,949Accounts receivable, net

6,1204,968I
'/>"/>

SOURCE Aware, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology news :

1. Aware, Inc. Reports Fourth Quarter and 2008 Financial Results
2. Aware, Inc. Commences Dutch Auction Tender Offer
3. Aware, Inc. Commences Dutch Auction Tender Offer
4. Aware, Inc. Amends and Extends Dutch Auction Tender Offer
5. Aware, Inc. Announces Preliminary Results of Dutch Auction Tender Offer
6. Aware, Inc. Amends and Extends Dutch Auction Tender Offer
7. Aware, Inc. Announces Q1 09 Earnings Conference Call
8. Aware, Inc. Announces Final Results of Dutch Auction Tender Offer
9. Aware, Inc. Reports First Quarter 2009 Financial Results
10. Aware, Inc. Reports First Quarter 2009 Financial Results
11. Aware, Inc. Announces Q209 Earnings Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... caesarean section rate, suggests a new commentary published today ... Obstetrics and Gynaecology (BJOG) . , China has one ... Of 16 million babies born in 2010, approximately half ... known, the current Chinese language literature on caesarean rates ... to 58%. However, before the 1980s, the caesarean rate ...
(Date:8/19/2014)... It,s not a lemur. It,s not an African Bush Baby ... tiny, adorable and downright "cool" primate from Southeast Asia. , ... with," said Rafe Brown, curator-in-charge at the University of Kansas, ... extremely cute, furry body; a long tail with a furry ... tips that look a bit like the disks on the ...
(Date:8/19/2014)... Some infants born with neonatal abstinence syndrome ... more difficult time going through withdrawal than others, ... While genetic and epigenetic (when genes are turned ... as potential factors, researchers at Boston University School ... conducted a first of its kind study to ...
Breaking Biology News(10 mins):Is China's 50 percent cesarean section delivery rate too high? 2Is China's 50 percent cesarean section delivery rate too high? 3Philippine tarsier gets boost from Kansas research, and genetic proof of a new variety 2Philippine tarsier gets boost from Kansas research, and genetic proof of a new variety 3In-utero methadone, Subutex exposure could alter gene expression, cause severe Neonatal Abstience Syndrome 2
... this weeks PLoS Medicine, researchers have found that more ... infectious eye disease trachoma. Six million people most ... the developing world are blind because of the ... that multiple strains of the Chlamydiceae family of bacteria ...
... Hydrogen peroxide, the same mild acid that many people use ... also produced by the body to keep cells healthy. Now, ... how part of this complex process works. Reporting ... by W. Todd Lowther, Ph.D., developed a three-dimensional snapshot of ...
... coalition of 17 organizations, including the National Academy ... the National Science Teachers Association, is calling on ... the promotion of science education, including evolution. According ... issue of The FASEB Journal, the introduction of ...
Cached Biology News:Multiple species of bacteria may cause trachoma: Implications for treatment 2Research explores role of hydrogen peroxide in cell health 2Evolution education is a 'must' says coalition of scientific and teaching organizations 2
(Date:8/20/2014)... Aug. 20, 2014  Decision Resources Group finds that the vascular ... Russia , India and ... 2013, roughly equal to the size of the United ... market will experience much faster growth as a result of strong ... Other key findings from Decision Resources Group,s coverage of the ...
(Date:8/20/2014)... 20, 2014 Not long ago, it ... should be performed late in the development cycle – ... current regulatory trends suggest that, like many things GxP, ... In recent years, multiple drug sponsors have been required ... specific questions during phase I/II. It’s not only clinical ...
(Date:8/20/2014)... WriteResult®, a leading provider of Electronic Patient ... its myPROpad™ ePRO tablet with the addition of a ... most widely used and well-respected Patient Reported Outcome (PRO) ... is used during clinical trials and in other health ... used to demonstrate Health-Related Quality of Life outcomes (HRQoL) ...
(Date:8/19/2014)... 19, 2014 Shimadzu Scientific Instruments ... Prominence-i and Nexera-i, adding to the company’s extensive ... functionality, an intuitive operating environment, and full automation, ... efficient workflow for conventional to ultra-high-speed analysis. ... and intelligent design so users can begin building ...
Breaking Biology Technology:BRIC Vascular Access Device Market Valued at $1.6 Billion in 2013, Similar to the U.S. Market 2BRIC Vascular Access Device Market Valued at $1.6 Billion in 2013, Similar to the U.S. Market 3Are Extractable and Leachables going Phase-Appropriate? New Webinar Hosted by Xtalks 2EQ-5D™ Assessment Now Available for iPad 2Shimadzu’s New i-Series Integrated Liquid Chromatography Systems Provide Laboratories Wider Range of Analytical Capabilities 2Shimadzu’s New i-Series Integrated Liquid Chromatography Systems Provide Laboratories Wider Range of Analytical Capabilities 3
... 10, 2011 Verenium Corporation (Nasdaq: VRNM ... development and commercialization of high-performance enzymes, today reported a ... the third quarter and nine months ended September 30, ... operational progress in the first nine months of this ...
... Science (Tianjin) Co. Ltd., a leading research-based contract manufacturer of ... sites in the U.S. and China, was pleased to receive ... and manufacturing facility on the afternoon of October 24th, 2011. ... Political Bureau of the CPC Central Committee and Premier of ...
... UV Flu Technologies, Inc. ( OTCBB: UVFT ... has expanded its International Distribution by adding representation in Oman, ... the Company,s Distributor in India, Ormed Systems, a leader in ... other parts of the world. The Company continues efforts in ...
Cached Biology Technology:Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011 2Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011 3Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011 4Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011 5Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011 6Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011 7Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011 8Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011 9Premier Wen Visits Asymchem's Tianjin Facility 2UV Flu Technologies Expands Its International Footprint 2UV Flu Technologies Expands Its International Footprint 3
Rac 1/2/3/4 (S-18)...
... Recognizes K+ Cl- ... shows no significant sequence ... or CCC.,SPECIES REACTIVITIES: The ... conserved in human, mouse, ...
Anti-G-alpha-i 1 G-Protein Host: mouse monoclonal Species Reactivity: human, mouse, rat Applications: WB Storage: 4C...
Mouse monoclonal [DAPK-55] to DAP Kinase 1 ( Abpromise for all tested applications). entrezGeneID: 1612 SwissProtID: P53355...
Biology Products: